ATE174899T1 - Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE174899T1 ATE174899T1 AT94306522T AT94306522T ATE174899T1 AT E174899 T1 ATE174899 T1 AT E174899T1 AT 94306522 T AT94306522 T AT 94306522T AT 94306522 T AT94306522 T AT 94306522T AT E174899 T1 ATE174899 T1 AT E174899T1
- Authority
- AT
- Austria
- Prior art keywords
- cytotoxic
- pharmaceutical compositions
- compositions containing
- containing same
- carbon atoms
- Prior art date
Links
- 231100000433 cytotoxic Toxicity 0.000 title 1
- 230000001472 cytotoxic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PJANXHGTPQOBST-VAWYXSNFSA-N trans-stilbene Chemical class C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002560 nitrile group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/164—Unsaturated ethers containing six-membered aromatic rings
- C07C43/166—Unsaturated ethers containing six-membered aromatic rings having unsaturation outside the aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22357393 | 1993-09-08 | ||
| JP32283293 | 1993-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE174899T1 true ATE174899T1 (de) | 1999-01-15 |
Family
ID=26525559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94306522T ATE174899T1 (de) | 1993-09-08 | 1994-09-05 | Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5525632A (de) |
| EP (1) | EP0641767B1 (de) |
| JP (1) | JP3045017B2 (de) |
| KR (1) | KR100308463B1 (de) |
| CN (1) | CN1035996C (de) |
| AT (1) | ATE174899T1 (de) |
| CA (1) | CA2131683C (de) |
| DE (1) | DE69415445T2 (de) |
| DK (1) | DK0641767T3 (de) |
| ES (1) | ES2126068T3 (de) |
| GR (1) | GR3029603T3 (de) |
| SI (1) | SI0641767T1 (de) |
| TW (1) | TW325458B (de) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW334418B (en) * | 1995-03-07 | 1998-06-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions |
| NZ507221A (en) | 1998-04-03 | 2003-04-29 | Ajinomoto Kk | Antitumor agent |
| US6624197B1 (en) | 1998-05-08 | 2003-09-23 | Calyx Therapeutics, Inc. | Diphenylethylene compounds |
| US6245814B1 (en) | 1998-05-08 | 2001-06-12 | Calyx Therapeutics, Inc. | Diphenylethylene compounds |
| US7105552B2 (en) | 1998-05-08 | 2006-09-12 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6331633B1 (en) | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
| GB9903403D0 (en) * | 1999-02-16 | 1999-04-07 | Angiogene Pharm Ltd | Substituted stilbene compounds with vascular damaging activity |
| US7407978B2 (en) * | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| GB9918912D0 (en) * | 1999-08-12 | 1999-10-13 | Angiogene Pharm Ltd | New stilbenes with vascular damaging activity |
| US6849656B1 (en) * | 1999-09-17 | 2005-02-01 | Baylor University | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| US7323496B2 (en) * | 1999-11-08 | 2008-01-29 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
| US6525093B1 (en) * | 1999-11-08 | 2003-02-25 | Calyx Therapeutics Inc. | Compounds to treat diabetes and associated conditions |
| US20080108825A1 (en) * | 1999-11-08 | 2008-05-08 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
| US20020002200A1 (en) * | 2000-02-04 | 2002-01-03 | Bishwagit Nag | Novel diphenylethylene compounds |
| DE60137020D1 (de) * | 2000-02-04 | 2009-01-29 | Theracos Inc | Neue diphenylethylene-verbindungen |
| US20080103302A1 (en) * | 2000-02-04 | 2008-05-01 | Theracos, Inc. | Compounds for treatment of inflammation, diabetes and related disorders |
| DE60129536T2 (de) | 2000-03-10 | 2008-06-19 | Baylor University, Waco | Tubulin bindende liganden |
| DE60107234T2 (de) * | 2000-05-09 | 2005-10-27 | Arizona Board of Regents, acting for and on behalf of Arizona State University, Tempe | Antitubulinanordnung und zellenwachstumshemmstoff "dioxostatin" |
| KR100742524B1 (ko) * | 2000-10-27 | 2007-08-02 | 아방티 파르마 소시에테 아노님 | 캄프토테신과 스틸벤 유도체를 포함하는 암 치료용 약제학적 병용제제 |
| CA2432640A1 (en) * | 2000-12-21 | 2002-06-27 | Cancer Research Technology Limited | Substituted stilbenes, their reactions and anticancer activity |
| US20020183266A1 (en) * | 2001-03-15 | 2002-12-05 | Aventis Pharma, S.A. | Combination comprising combretastatin and anticancer agents |
| WO2003000645A1 (en) * | 2001-06-22 | 2003-01-03 | Ajinomoto Co., Inc. | Method for producing aminostilbene derivative |
| EP1407784B1 (de) * | 2001-06-25 | 2010-11-24 | Ajinomoto Co., Inc. | Antitumorale mittel |
| AU2002323417B2 (en) * | 2001-08-27 | 2008-05-15 | The Trustees Of The University Of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
| JP2005507912A (ja) * | 2001-10-26 | 2005-03-24 | オキシジーン， インコーポレイテッド | 改良型血管標的化剤としての官能化スチルベン誘導体 |
| US6759555B2 (en) * | 2002-04-11 | 2004-07-06 | Aventis Pharma S.A. | Process for the preparation of combretastatins |
| FR2838437B1 (fr) * | 2002-04-11 | 2004-06-04 | Aventis Pharma Sa | Procedes de preparation de combretastatines |
| CA2515174A1 (en) * | 2003-02-04 | 2004-08-19 | Kabushiki Kaisha Yakult Honsha | Breast cancer resistance protein (bcrp) inhibitor |
| CA2516078C (en) * | 2003-02-28 | 2014-04-29 | Oxigene, Inc. | Catechol compositions and use thereof |
| CN1723884A (zh) | 2004-07-21 | 2006-01-25 | 中国人民解放军军事医学科学院放射医学研究所 | 顺式－1，2－取代的二苯乙烯衍生物用于制备治疗或预防糖尿病的药物的用途 |
| US7807135B2 (en) * | 2004-12-17 | 2010-10-05 | The Trustees Of The University Of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
| US7858072B2 (en) * | 2004-12-17 | 2010-12-28 | The Trustees Of The University Of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
| FR2895258B1 (fr) * | 2005-12-22 | 2008-03-21 | Aventis Pharma Sa | Combinaison comprenant de la combretastatine et des agents anticancereux |
| CN101139358B (zh) * | 2006-09-07 | 2011-10-12 | 浙江大德药业集团有限公司 | 乙氧基康普立停及其前药的制备和用途 |
| TW200819409A (en) * | 2006-10-19 | 2008-05-01 | Univ Taipei Medical | Z-stilbenes derivatives and the pharmaceutical composition thereof |
| CN100532353C (zh) * | 2006-12-06 | 2009-08-26 | 中国科学院广州化学研究所 | (z)-3＇-氨基-3,4,4＇,5-四甲氧基二苯乙烯的制备方法 |
| US20090192098A1 (en) | 2007-11-21 | 2009-07-30 | Oxigene, Inc. | Method for treating hematopoietic neoplasms |
| CN101450889B (zh) * | 2007-12-03 | 2012-05-30 | 中国科学院理化技术研究所 | 光催化1,2-二苯乙烯类似物发生顺反异构化反应的方法 |
| FR2928148B1 (fr) | 2008-02-28 | 2013-01-18 | Sanofi Aventis | Procede de preparation de combretastatine |
| CN101723813A (zh) * | 2008-10-15 | 2010-06-09 | 上海华理生物医药有限公司 | 一种乙氧基二苯乙烷衍生物及其制备方法和用途 |
| FR2953518B1 (fr) * | 2009-12-03 | 2012-01-20 | Sanofi Aventis | Procede de preparation d'un derive de combretastatine |
| FR2968557A1 (fr) | 2010-12-09 | 2012-06-15 | Sanofi Aventis | Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab |
| CN110015962B (zh) * | 2011-01-28 | 2022-03-15 | 肯塔基大学研究基金会 | 茋类似物和治疗癌症的方法 |
| EP2724156B1 (de) | 2011-06-27 | 2017-08-16 | The Jackson Laboratory | Verfahren und zusammensetzungen zur behandlung von krebs und autoimmunerkrankungen |
| CN103288701B (zh) * | 2012-02-24 | 2016-01-27 | 中南大学 | 1，5-二芳基吡咯衍生物、制备方法及其抗肿瘤应用 |
| US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
| US10201623B2 (en) | 2013-03-15 | 2019-02-12 | Memorial Sloan Kettering Cancer Center | HSP90-targeted cardiac imaging and therapy |
| WO2017031157A1 (en) | 2015-08-18 | 2017-02-23 | Mateon Therapeutics, Inc. | Use of vdas to enhance immunomodulating therapies against tumors |
| WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
| CN108727222B (zh) * | 2017-04-24 | 2020-12-08 | 延边大学 | 一种选择性抗癌活性的tyd1608及其制备及用途 |
| WO2018209239A1 (en) | 2017-05-11 | 2018-11-15 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
| US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
| WO2020247054A1 (en) | 2019-06-05 | 2020-12-10 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
| WO2022182415A1 (en) | 2021-02-24 | 2022-09-01 | Massachusetts Institute Of Technology | Himastatin derivatives, and processes of preparation thereof, and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3832204A1 (de) * | 1988-09-22 | 1990-03-29 | Basf Ag | Neue stilbenverbindungen und deren verwendung bei der anionischen polymerisation |
| US5430062A (en) * | 1992-05-21 | 1995-07-04 | Research Corporation Technologies, Inc. | Stilbene derivatives as anticancer agents |
| EP0641301A1 (de) * | 1992-05-21 | 1995-03-08 | Research Corporation Technologies, Inc. | Stilbenderivate als antikrebsmittel |
-
1994
- 1994-08-26 TW TW083107859A patent/TW325458B/zh not_active IP Right Cessation
- 1994-09-05 DK DK94306522T patent/DK0641767T3/da active
- 1994-09-05 EP EP94306522A patent/EP0641767B1/de not_active Expired - Lifetime
- 1994-09-05 DE DE69415445T patent/DE69415445T2/de not_active Expired - Lifetime
- 1994-09-05 AT AT94306522T patent/ATE174899T1/de active
- 1994-09-05 SI SI9430218T patent/SI0641767T1/xx unknown
- 1994-09-05 ES ES94306522T patent/ES2126068T3/es not_active Expired - Lifetime
- 1994-09-06 JP JP6236046A patent/JP3045017B2/ja not_active Expired - Lifetime
- 1994-09-07 KR KR1019940022423A patent/KR100308463B1/ko not_active Expired - Lifetime
- 1994-09-08 US US08/302,210 patent/US5525632A/en not_active Expired - Lifetime
- 1994-09-08 CA CA002131683A patent/CA2131683C/en not_active Expired - Lifetime
- 1994-09-08 CN CN94116204A patent/CN1035996C/zh not_active Expired - Lifetime
-
1999
- 1999-03-08 GR GR990400690T patent/GR3029603T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3029603T3 (en) | 1999-06-30 |
| CA2131683A1 (en) | 1995-03-09 |
| CA2131683C (en) | 2005-01-25 |
| TW325458B (en) | 1998-01-21 |
| US5525632A (en) | 1996-06-11 |
| DK0641767T3 (da) | 1999-08-23 |
| DE69415445D1 (de) | 1999-02-04 |
| ES2126068T3 (es) | 1999-03-16 |
| EP0641767A1 (de) | 1995-03-08 |
| SI0641767T1 (en) | 1999-04-30 |
| DE69415445T2 (de) | 1999-07-22 |
| CN1035996C (zh) | 1997-10-01 |
| KR950008476A (ko) | 1995-04-17 |
| EP0641767B1 (de) | 1998-12-23 |
| JPH07228558A (ja) | 1995-08-29 |
| CN1105967A (zh) | 1995-08-02 |
| KR100308463B1 (ko) | 2001-12-01 |
| JP3045017B2 (ja) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE174899T1 (de) | Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE185792T1 (de) | Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen | |
| GR3019341T3 (en) | USE OF AN alpha-tocoPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED | |
| FR2669336B1 (fr) | Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| KR950000728A (ko) | 포스포네이트 뉴클레오티드 에스테르 유도체 | |
| EP0487502A3 (en) | Pharmaceutically active aryl-substituted amine derivatives | |
| IL114785A0 (en) | Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them | |
| DK0420121T3 (da) | Antitumormiddel | |
| ES2055235T3 (es) | Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation. | |
| AR007052A1 (es) | Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende | |
| FR2623504B1 (fr) | Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| MX9206930A (es) | Nuevos compuestos | |
| DE69001004D1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| ATE1598T1 (de) | 5(10- 9)abeo-ergolin-derivate, ihre herstellung und sie enthaltende therapeutische zusammensetzungen. | |
| ATE184282T1 (de) | Cyclopropan-derivate und diese enthaltende antivirale mittel | |
| FI895139A0 (fi) | Pyrrolidinderivat. | |
| ATE147755T1 (de) | Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten | |
| ATE115582T1 (de) | Cephalosporinderivate. | |
| IL106564A (en) | Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
| MY104099A (en) | Anti inflammatory carbinoloimidazoles. | |
| DK460789A (da) | 2-aminoacetamidderivater | |
| TH20908B (th) | อนุพันธ์คาร์โบไฮเดรต | |
| WO2003014089A8 (en) | Aminotetrahydroisoquinoline derivatives as analgesics | |
| TH31635A (th) | อนุพันธ์คาร์โบไฮเดรต |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |